{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:12:06Z","timestamp":1792782726360,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Torino","id":[{"id":"https:\/\/ror.org\/048tbm396","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Levodopa-induced dyskinesia (LID) is a major source of disability in advanced Parkinson\u2019s disease (PD), whose impact on gait and balance across medication states still remains unclear. We aimed to compare gait and balance performance between comparable dyskinetic (Dysk-matched) and non-dyskinetic (No-Dysk) PD patients in OFF and ON state, and to explore neural correlates using structural and resting-state functional MRI (rs-fMRI). PD patients were consecutively enrolled among candidates for device-aided therapies. Gait and balance were assessed using validated wearable inertial sensors during a 2-minute walk test, a 3-meters Timed-Up-and-Go (TUG), and a sway test, providing spatiotemporal gait parameters, variability, asymmetry, and postural sway metrics. Groups were compared using propensity score matching (PSM) for age, sex, disease duration, motor severity and axial disability. A subgroup underwent exploratory investigation with structural and rs-fMRI collected in ON state. After PSM (22 pairs), Dysk-matched group showed slower gait speed (\n                    <jats:italic>p\u2009=\u20090.007<\/jats:italic>\n                    ), shorter stride length (\n                    <jats:italic>p\u2009=\u20090.006<\/jats:italic>\n                    ), longer double support (\n                    <jats:italic>p\u2009=\u20090.047<\/jats:italic>\n                    ), and prolonged TUG (\n                    <jats:italic>p\u2009=\u20090.049<\/jats:italic>\n                    ) in the OFF state. Dysk-matched patients showed increased sway from OFF to ON (\n                    <jats:italic>p\u2009=\u20090.030<\/jats:italic>\n                    ). Neuroimaging (10 Dysk-matched, 9 No-Dysk) revealed increased functional connectivity in sensorimotor regions and reduced SMA connectivity within a cerebellar network in Dysk-matched patients, without structural difference. Overall, the association of LID with impaired gait and postural control even in the OFF state is consistent with the hypothesis of broader motor network dysfunction beyond overt involuntary movements.\n                  <\/jats:p>","DOI":"10.1007\/s00702-026-03217-w","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:25:49Z","timestamp":1782858349000},"page":"2589-2598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Levodopa-induced dyskinesia is associated with worse gait and balance in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4842-529X","authenticated-orcid":false,"given":"Gabriele","family":"Imbalzano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"D\u2019Agata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Ledda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Alberto","family":"Artusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Laudadio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Romagnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Giorgio","family":"Rizzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Lopiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Zibetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bozzali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"issue":"13","key":"3217_CR1","doi-asserted-by":"publisher","first-page":"112421","DOI":"10.1016\/j.jbiomech.2024.112421","volume":"177","author":"JA Aderonmu","year":"2024","unstructured":"Aderonmu JA, Curtze C (2024) Levodopa-induced dyskinesia alters postural control in people with Parkinson\u2019s disease. J Biomech 177(13):112421. https:\/\/doi.org\/10.1016\/j.jbiomech.2024.112421","journal-title":"J Biomech"},{"issue":"6","key":"3217_CR2","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson disease: a review. JAMA 323(6):548\u2013560. https:\/\/doi.org\/10.1001\/jama.2019.22360","journal-title":"JAMA"},{"key":"3217_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bbr.2017.05.033","volume":"331","author":"CT Bonnet","year":"2017","unstructured":"Bonnet CT, Delval A, Szaffarczyk S, Defebvre L (2017) Levodopa has primarily negative influences on postural control in patients with Parkinson\u2019s disease. Behav Brain Res 331:67\u201375. https:\/\/doi.org\/10.1016\/j.bbr.2017.05.033","journal-title":"Behav Brain Res"},{"issue":"13","key":"3217_CR4","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.3390\/s25134071","volume":"25","author":"M Bradley","year":"2025","unstructured":"Bradley M, O\u2019Loughlin S, Donlon E et al (2025) Determining falls risk in people with Parkinson\u2019s disease using wearable sensors: a systematic review. Sens (Basel) 25(13):4071. https:\/\/doi.org\/10.3390\/s25134071","journal-title":"Sens (Basel)"},{"issue":"9","key":"3217_CR5","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1179\/1743132811Y.0000000044","volume":"33","author":"MS Bryant","year":"2011","unstructured":"Bryant MS, Rintala DH, Hou JG, Charness AL, Fernandez AL, Collins RL, Protas EJ (2011) Gait variability in Parkinson\u2019s disease: influence of walking speed and dopaminergic treatment. Neurol Res 33(9):959\u2013964. https:\/\/doi.org\/10.1179\/1743132811Y.0000000044","journal-title":"Neurol Res"},{"issue":"3","key":"3217_CR6","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/mds.27959","volume":"35","author":"MA Cenci","year":"2020","unstructured":"Cenci MA, Riggare S, Pahwa R, Eidelberg D, Hauser RA (2020) Dyskinesia matters. Mov Disord 35(3):392\u2013396. https:\/\/doi.org\/10.1002\/mds.27959","journal-title":"Mov Disord"},{"issue":"3","key":"3217_CR7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/mds.24017","volume":"27","author":"A Cerasa","year":"2012","unstructured":"Cerasa A, Pugliese P, Messina D et al (2012) Prefrontal alterations in Parkinson\u2019s disease with levodopa-induced dyskinesia during fMRI motor task. Mov Disord 27(3):364\u2013371. https:\/\/doi.org\/10.1002\/mds.24017","journal-title":"Mov Disord"},{"issue":"Pt 2","key":"3217_CR8","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/brain\/awu329","volume":"138","author":"A Cerasa","year":"2015","unstructured":"Cerasa A, Koch G, Donzuso G et al (2015) A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias. Brain 138(Pt 2):414\u2013427. https:\/\/doi.org\/10.1093\/brain\/awu329","journal-title":"Brain"},{"key":"3217_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2024.103705","volume":"44","author":"BL Chen Thomsen","year":"2024","unstructured":"Chen Thomsen BL, Vinding MC, Meder D et al (2024) Functional motor network abnormalities associated with levodopa-induced dyskinesia in Parkinson\u2019s disease: a systematic review. Neuroimage Clin 44:103705","journal-title":"Neuroimage Clin"},{"issue":"4","key":"3217_CR10","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1016\/j.neuroimage.2009.10.090","volume":"49","author":"J Chumbley","year":"2010","unstructured":"Chumbley J, Worsley K, Flandin G, Friston K (2010) Topological FDR for neuroimaging. NeuroImage 49(4):3057\u20133064. https:\/\/doi.org\/10.1016\/j.neuroimage.2009.10.090","journal-title":"NeuroImage"},{"issue":"10","key":"3217_CR11","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/mds.26269","volume":"30","author":"C Curtze","year":"2015","unstructured":"Curtze C, Nutt JG, Carlson-Kuhta P, Mancini M, Horak FB (2015) Levodopa is a double-edged sword for balance and gait in people with Parkinson\u2019s disease. Mov Disord 30(10):1361\u20131370. https:\/\/doi.org\/10.1002\/mds.26269","journal-title":"Mov Disord"},{"issue":"19","key":"3217_CR12","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/WNL.0b013e3181fc29c9","volume":"75","author":"JC Dalrymple-Alford","year":"2010","unstructured":"Dalrymple-Alford JC, MacAskill MR, Nakas CT et al (2010) The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology 75(19):1717\u20131725. https:\/\/doi.org\/10.1212\/WNL.0b013e3181fc29c9","journal-title":"Neurology"},{"issue":"7","key":"3217_CR13","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/mds.29066","volume":"37","author":"G Deuschl","year":"2022","unstructured":"Deuschl G, Antonini A, Costa J et al (2022) European academy of neurology\/movement disorder society-European section guideline on the treatment of Parkinson\u2019s disease: I. invasive therapies. Mov Disord 37(7):1360\u20131374. https:\/\/doi.org\/10.1002\/mds.29066","journal-title":"Mov Disord"},{"issue":"1\u20132","key":"3217_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jns.2014.07.026","volume":"345","author":"DC Dewey","year":"2014","unstructured":"Dewey DC, Miocinovic S, Bernstein I et al (2014) Automated gait and balance parameters diagnose and correlate with severity in Parkinson disease. J Neurol Sci 345(1\u20132):131\u2013138. https:\/\/doi.org\/10.1016\/j.jns.2014.07.026","journal-title":"J Neurol Sci"},{"issue":"5","key":"3217_CR15","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1111\/1475-6773.12182","volume":"49","author":"MM Garrido","year":"2014","unstructured":"Garrido MM, Kelley AS, Paris J et al (2014) Methods for constructing and assessing propensity scores. Health Serv Res 49(5):1701\u20131720. https:\/\/doi.org\/10.1111\/1475-6773.12182","journal-title":"Health Serv Res"},{"key":"3217_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fneur.2019.00005","volume":"10","author":"H Ga\u00dfner","year":"2019","unstructured":"Ga\u00dfner H, Raccagni C, Eskofier BM, Klucken J, Wenning GK (2019) The diagnostic scope of sensor-based gait analysis in atypical Parkinsonism: further observations. Front Neurol 10:5. https:\/\/doi.org\/10.3389\/fneur.2019.00005","journal-title":"Front Neurol"},{"issue":"6","key":"3217_CR17","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/ana.24138","volume":"75","author":"DM Herz","year":"2014","unstructured":"Herz DM, Haagensen BN, Christensen MS et al (2014) The acute brain response to levodopa heralds dyskinesias in Parkinson disease. Ann Neurol 75(6):829\u2013836. https:\/\/doi.org\/10.1002\/ana.24138","journal-title":"Ann Neurol"},{"issue":"Pt 6","key":"3217_CR18","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1093\/brain\/awv096","volume":"38","author":"DM Herz","year":"2015","unstructured":"Herz DM, Haagensen BN, Christensen MS et al (2015) Abnormal dopaminergic modulation of striato-cortical networks underlies levodopa-induced dyskinesias in humans. Brain 38(Pt 6):1658\u20131666. https:\/\/doi.org\/10.1093\/brain\/awv096","journal-title":"Brain"},{"issue":"1","key":"3217_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/ene.15558","volume":"30","author":"G Imbalzano","year":"2023","unstructured":"Imbalzano G, Rinaldi D, Calandra-Buonaura G et al (2023) How resistant are levodopa-resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease. Eur J Neurol 30(1):96\u2013106. https:\/\/doi.org\/10.1111\/ene.15558","journal-title":"Eur J Neurol"},{"issue":"6","key":"3217_CR20","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s10286-024-01071-y","volume":"34","author":"G Imbalzano","year":"2024","unstructured":"Imbalzano G, Ledda C, Tangari MM et al (2024) Unraveling the stride: exploring the influence of neurogenic orthostatic hypotension on gait and balance in Parkinson\u2019s disease. Clin Auton Res 34(6):593\u2013601. https:\/\/doi.org\/10.1007\/s10286-024-01071-y","journal-title":"Clin Auton Res"},{"issue":"7","key":"3217_CR21","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/mds.29410","volume":"38","author":"ST Jost","year":"2023","unstructured":"Jost ST, Kaldenbach MA, Antonini A et al (2023) Levodopa dose equivalency in Parkinson\u2019s disease: updated systematic review and proposals. Mov Disord 38(7):1236\u20131252. https:\/\/doi.org\/10.1002\/mds.29410","journal-title":"Mov Disord"},{"issue":"11","key":"3217_CR22","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1002\/mds.28684","volume":"36","author":"B Maiti","year":"2021","unstructured":"Maiti B, Rawson KS, Tanenbaum AB et al (2021) Functional connectivity of vermis correlates with future gait impairments in Parkinson\u2019s disease. Mov Disord 36(11):2559\u20132568. https:\/\/doi.org\/10.1002\/mds.28684","journal-title":"Mov Disord"},{"key":"3217_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.neuropharm.2015.06.004","volume":"97","author":"C Marin","year":"2015","unstructured":"Marin C, Bonastre M, Mengod G, Cort\u00e9s R, Rodr\u00edguez-Oroz MC (2015) From unilateral to bilateral parkinsonism: effects of lateralization on dyskinesias and associated molecular mechanisms. Neuropharmacology 97:365\u2013375. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.06.004","journal-title":"Neuropharmacology"},{"key":"3217_CR24","first-page":"96","volume-title":"Movement disorders","author":"CD Marsden","year":"1982","unstructured":"Marsden CD, Parkes JD, Quinn N (1982) Fluctuations of disability in Parkinson\u2019s disease: clinical aspects. In: Marsden CD, Fahn S (eds) Movement disorders. Butterworths, London, pp 96\u2013122"},{"issue":"9","key":"3217_CR25","doi-asserted-by":"publisher","first-page":"095003","DOI":"10.1088\/1361-6579\/ab4023","volume":"40","author":"R Morris","year":"2019","unstructured":"Morris R, Stuart S, Mcbarron G, Fino PC, Mancini M, Curtze C (2019) Validity of mobility lab (version 2) for gait assessment in young adults, older adults and Parkinson\u2019s disease. Physiol Meas 40(9):095003. https:\/\/doi.org\/10.1088\/1361-6579\/ab4023","journal-title":"Physiol Meas"},{"key":"3217_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.56441\/hilbertpress.2207.6598","volume-title":"Handbook of functional connectivity magnetic resonance imaging methods in CONN","author":"A Nieto-Castanon","year":"2020","unstructured":"Nieto-Castanon A (2020) Handbook of functional connectivity magnetic resonance imaging methods in CONN. Hilbert Press, pp 17\u201325"},{"issue":"3","key":"3217_CR27","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.25170","volume":"83","author":"L Norcliffe-Kaufmann","year":"2018","unstructured":"Norcliffe-Kaufmann L, Kaufmann H, Palma JA et al (2018) Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies. Ann Neurol 83(3):522\u2013531. https:\/\/doi.org\/10.1002\/ana.25170","journal-title":"Ann Neurol"},{"issue":"12","key":"3217_CR28","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"issue":"10","key":"3217_CR29","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s00702-015-1396-2","volume":"122","author":"O Rascol","year":"2015","unstructured":"Rascol O, Perez-Lloret S, Damier P et al (2015) Falls in ambulatory non-demented patients with Parkinson\u2019s disease. J Neural Transm (Vienna) 122(10):1447\u20131455. https:\/\/doi.org\/10.1007\/s00702-015-1396-2","journal-title":"J Neural Transm (Vienna)"},{"key":"3217_CR30","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fneur.2013.00202","volume":"4","author":"FJ Revilla","year":"2013","unstructured":"Revilla FJ, Larsh TR, Mani A et al (2013) Effect of dopaminergic medication on postural sway in advanced Parkinson\u2019s disease. Front Neurol 4:202. https:\/\/doi.org\/10.3389\/fneur.2013.00202","journal-title":"Front Neurol"},{"issue":"23","key":"3217_CR31","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.1113\/JP280156","volume":"598","author":"FE Roux","year":"2020","unstructured":"Roux FE, Niare M, Charni S, Giussani C, Durand JB (2020) Functional architecture of the motor homunculus detected by electrostimulation. J Physiol 598(23):5487\u20135504. https:\/\/doi.org\/10.1113\/JP280156","journal-title":"J Physiol"},{"issue":"4","key":"3217_CR32","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/1971400917697342","volume":"30","author":"KA Smitha","year":"2017","unstructured":"Smitha KA, Akhil Raja K, Arun KM et al (2017) Resting state fMRI: a review on methods in resting state connectivity analysis and resting state networks. Neuroradiol J 30(4):305\u2013317. https:\/\/doi.org\/10.1177\/1971400917697342","journal-title":"Neuroradiol J"},{"key":"3217_CR33","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3389\/fnins.2016.00515","volume":"10","author":"JM Soares","year":"2016","unstructured":"Soares JM, Magalh\u00e3es R, Moreira PS et al (2016) A Hitchhiker\u2019s guide to functional magnetic resonance imaging. Front Neurosci 10:515. https:\/\/doi.org\/10.3389\/fnins.2016.00515","journal-title":"Front Neurosci"},{"issue":"3","key":"3217_CR34","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00221-011-2845-2","volume":"214","author":"JK Stevenson","year":"2011","unstructured":"Stevenson JK, Talebifard P, Ty E, Oishi MM, McKeown MJ (2011) Dyskinetic Parkinson\u2019s disease patients demonstrate motor abnormalities off medication. Exp Brain Res 214(3):471\u2013479. https:\/\/doi.org\/10.1007\/s00221-011-2845-2","journal-title":"Exp Brain Res"},{"issue":"4","key":"3217_CR35","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/mds.29320","volume":"38","author":"D Su","year":"2023","unstructured":"Su D, Gan Y, Zhang Z et al (2023) Multimodal Imaging of substantia nigra in Parkinson\u2019s disease with levodopa-induced dyskinesia. Mov Disord 38(4):616\u2013625. https:\/\/doi.org\/10.1002\/mds.29320","journal-title":"Mov Disord"},{"issue":"1","key":"3217_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14802\/jmd.16062","volume":"10","author":"K Takakusaki","year":"2017","unstructured":"Takakusaki K (2017) Functional neuroanatomy for posture and gait control. J Mov Disord 10(1):1\u201317. https:\/\/doi.org\/10.14802\/jmd.16062","journal-title":"J Mov Disord"},{"issue":"8","key":"3217_CR37","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00702-018-1900-6","volume":"125","author":"TN Tran","year":"2018","unstructured":"Tran TN, Vo TNN, Frei K, Truong DD (2018) Levodopa-induced dyskinesia: clinical features, incidence, and risk factors. J Neural Transm (Vienna) 125(8):1109\u20131117. https:\/\/doi.org\/10.1007\/s00702-018-1900-6","journal-title":"J Neural Transm (Vienna)"},{"issue":"24","key":"3217_CR38","doi-asserted-by":"publisher","first-page":"e2238","DOI":"10.1212\/WNL.0000000000006643","volume":"91","author":"P Turcano","year":"2018","unstructured":"Turcano P, Mielke MM, Bower JH et al (2018) Levodopa-induced dyskinesia in Parkinson disease: a population-based cohort study. Neurology 91(24):e2238\u2013e2243. https:\/\/doi.org\/10.1212\/WNL.0000000000006643","journal-title":"Neurology"},{"issue":"6","key":"3217_CR39","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1111\/ejn.14114","volume":"48","author":"F Turco","year":"2018","unstructured":"Turco F, Canessa A, Olivieri C et al (2018) Cortical response to levodopa in Parkinson\u2019s disease patients with dyskinesias. Eur J Neurosci 48(6):2362\u20132373. https:\/\/doi.org\/10.1111\/ejn.14114","journal-title":"Eur J Neurosci"},{"issue":"7","key":"3217_CR40","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s40265-016-0566-3","volume":"76","author":"D Vijayakumar","year":"2016","unstructured":"Vijayakumar D, Jankovic J (2016) Drug-induced dyskinesia, part 1: treatment of levodopa-induced dyskinesia. Drugs 76(7):759\u2013777.","journal-title":"Drugs"},{"issue":"12","key":"3217_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0261302","volume":"16","author":"S Virameteekul","year":"2021","unstructured":"Virameteekul S, Phokaewvarangkul O, Bhidayasiri R (2021) Profiling the most elderly Parkinson\u2019s disease patients: does age or disease duration matter? PLoS One 16(12):e0261302. https:\/\/doi.org\/10.1371\/journal.pone.0261302","journal-title":"PLoS One"},{"key":"3217_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/mds.70097","author":"S Virameteekul","year":"2025","unstructured":"Virameteekul S, Shin C, Hirczy SS et al (2025) Assessing digital health technologies for outcome measurement in parkinson\u2019s disease drug trials: a systematic review. Mov Disord. https:\/\/doi.org\/10.1002\/mds.70097","journal-title":"Mov Disord"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03217-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-026-03217-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03217-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:19:31Z","timestamp":1792577971000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-026-03217-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3217"],"URL":"https:\/\/doi.org\/10.1007\/s00702-026-03217-w","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}